<DOC>
	<DOCNO>NCT00854100</DOCNO>
	<brief_summary>This outpatient study evaluate safety , efficacy RGH-188 add-on therapy standard antidepressant patient respond previous antidepressant therapy .</brief_summary>
	<brief_title>Safety Efficacy Cariprazine As Adjunctive Therapy In Major Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>Men woman , 1865 year old Currently meet DSMIVTR criterion moderate severe MDD without psychotic feature . Previous failure respond adequate trial one two ADTs le 50 % reduction depressive symptom present episode . DSMIVTR base diagnosis axis I disorder , MDD , axis I disorder MDD primary focus treatment within 6 month Visit 1</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Adjunctive</keyword>
	<keyword>Depression</keyword>
	<keyword>Major Depressive Disorder ( MDD )</keyword>
</DOC>